Document is current
Any future updates will be listed below
-
Authors
Favereaux, Stéphane
Durlach, Vincent
Vercoustre, Bernard
-
Funding
Funding for this research was provided by:
Novartis
- License Information
-
More Information
Article History
Received: 4 March 2025
Accepted: 17 April 2025
First Online: 11 May 2025
Declarations
:
: Vincent Durlach has participated in clinical trials for Amgen, Sanofi, and Bioprojet; attended conferences, symposia, or training activities for Amgen, Sanofi, Servier, MSD, and Proofs and Practices; and has received travel support (transport, hotel, meals) to attend conferences from Laboratoires Servier, Amgen, Sanofi, and Novo Nordisk. Stéphane Favereaux and Bernard Vercoutre declare that they have no competing interests. Novartis provided funding for medical writing support in the development of this manuscript; this funding was not paid to the authors.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. The patient has consented to publication of this report.
